Aurinia Pharmaceuticals Inc. (AUPH) stock
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.40−0.08 (-0.52%)
Close on Nov 17, 2026Market cap $2.06BP/E 6.7Yield –
Aurinia Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aurinia Pharmaceuticals's market cap was $2.15B on Nov 11, 2026, against $2.13B a year earlier. Over the last 5 years it ranged from $613.92M to $2.96B, with a median of $1.29B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.15B | +2.5% |
| 2025 | Dec 31, 2025 | $2.10B | +63.6% |
| 2024 | Dec 31, 2024 | $1.29B | -0.5% |
| 2023 | Dec 29, 2023 | $1.29B | +110.3% |
| 2022 | Dec 30, 2022 | $613.92M | -79.3% |
| 2021 | Dec 31, 2021 | $2.96B | +91.6% |
| 2020 | Dec 31, 2020 | $1.55B | -10.7% |
| 2019 | Dec 31, 2019 | $1.73B | +230.2% |
| 2018 | Dec 31, 2018 | $524.58M | +228.2% |
| 2017 | Dec 29, 2017 | $159.84M | – |
See a number that looks wrong?